client logo
Version: 1.0.0 | Published: 25 Aug 2026 | Updated: 1 day ago

BODI Study: Body Composition in Older Adults with Cancer

Dataset

Documentation

Description:
The study recruited older adults (aged 70 years and over) with cancer, undergoing systemic anticancer treatment (e.g., chemotherapy), with view to advancing personalised care for this growing and typically underrepresented in research population. It was an observational study looking at body composition (the fat, muscle and water content of someone"s body), in order to explore the extent this changes and whether any changes are tumour specific - also the incidence for cancer-related cachexia and sarcopenia (muscle +/- fat wasting conditions), and finally, how body composition informs nutritional management in this population. Measurements included an analysis from the Bioelectrical Impedance Analysis (BIA) machine which quantifies fat, lean muscle, and water content; waist to hip ratio; handgrip strength; calf circumferences. Socio-demographic data also be collected - appropriate for descriptive analysis exploring possible trends and associations.

Coverage

Spatial:
Sutton LB, United Kingdom
Typical Age Range:
70-150
Follow Up:
0 - 6 Months
Pathway:
Potential participants identified from routine clinics: adults aged 70 years and older, with a cancer diagnosis who are about to receive systemic anti-cancer treatment. Inclusion criteria required that consenting participants able to provide at least 2 data sets during the study period (baseline + at least 1 research clinic visit) - with possible research clinics occurring monthly. Study duration of 7months - data to be censused at End of Study - meaning maximum theoretical follow-up of 7months, but practically 0-6months.

Provenance

Origin

Purposes:
Study
Sources:
Other
Collection Situations:
Cohort, study, trial

Temporal

Accrual Periodicity:
Static
Start Date:
13 February 2025
End Date:
12 September 2025
Time Lag:
Not applicable

Accessibility

Access

Access Rights:
in progress
Access Service:
Although not required, there is an option to use The Royal Marsden’s Trusted Research Environment and informatics platform: BRIDgE (Biomedical Research Informatics Digital Environment). BRIDgE is managed by The Royal Marsden’s Information Team with support by the NIHR Biomedical Research Centre at The Royal Marsden and ICR. The aim of the platform is to transform clinical practice and improve outcomes for patients by enabling researchers to access real-world cancer data within secure, collaborative, cloud-based workspaces. Learn more by visiting the BRIDgE site within the NIHR BRC area of The Royal Marsden and ICR website: https://www.cancerbrc.org/BRIDgE
Access Request Cost:
Depends on type of access. Costing available on application.
Delivery Lead Time:
Variable
Jurisdictions:
UK
Data Controller:
Royal Marsden NHS Foundation Trust
Data Processor:
Royal Marsden NHS Foundation Trust

Usage

Data Use Limitations:
Research-specific restrictions
Data Use Requirements:
  • Institution-specific restrictions
  • User-specific restriction
  • Ethics approval required
  • Not for profit use
Resource Creators:
The Royal Marsden NHS Foundation Trust; The Royal Marsden Cancer Charity; NIHR Biomedical Research Centre at The Royal Marsden and the ICR; Nutricia

Format and Standards

Vocabulary Encoding Schemes:
LOCAL
Conforms To:
LOCAL
Languages:
en
Formats:
csv